RRP4 Antibody

What is RRP4 and what cellular functions does it perform?

RRP4 (Ribosomal RNA-processing protein 4) is a non-catalytic component of the RNA exosome complex that possesses 3'→5' exoribonuclease activity. It participates in numerous cellular RNA processing and degradation events across different cellular compartments. In the nucleus, RRP4 contributes to the proper maturation of stable RNA species including rRNA, snRNA, and snoRNA, while also participating in the elimination of RNA processing by-products and non-coding transcripts. In the cytoplasm, RRP4 is involved in general mRNA turnover processes and specifically targets unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions. Additionally, it plays roles in RNA surveillance pathways, preventing the translation of aberrant mRNAs and contributing to histone mRNA degradation .

As part of the exosome complex, RRP4 functions as a peripheral component of the Exo-9 complex, stabilizing the hexameric ring of RNase PH-domain subunits through contacts with EXOSC4 and EXOSC7 . Notably, RRP4 confers strong poly(A) specificity to the exosome, which is significant for its selective RNA processing functions .

What types of RRP4 antibodies are commercially available and what are their sources?

Based on current research materials, there are two primary types of RRP4 antibodies available:

The polyclonal antibodies are typically developed against synthetic peptides or recombinant proteins corresponding to human RRP4. For example, Novus Biologicals' polyclonal antibody was developed against a recombinant protein corresponding to specific amino acids of the RRP4 protein sequence . The monoclonal antibody from Bio-Techne was developed against a synthetic peptide of human RRP4 (UniProt # Q13868) .

What is the expected molecular weight of RRP4 in Western blot applications?

The expected molecular weight of RRP4 in Western blot applications is approximately 33 kDa. This is consistent across multiple antibody supplier specifications and experimental observations .

The theoretical molecular weight is calculated based on the 293-amino acid sequence of the human RRP4 protein encoded by the EXOSC2 gene . It's important to note that researchers should be aware that the observed molecular weight may occasionally vary from the predicted weight due to post-translational modifications, cleavages, relative charges, and other experimental factors that can affect protein migration during gel electrophoresis .

What are the validated applications for RRP4 antibodies in research?

RRP4 antibodies have been validated for multiple experimental applications:

Western blot appears to be the most robustly validated application across different antibody products, with consistent detection of the target protein at approximately 33 kDa. The recommended working dilution for Western blot is typically 1:1000, though researchers should optimize conditions for their specific experimental systems .

What species reactivity is reported for commercial RRP4 antibodies?

The species reactivity of commercial RRP4 antibodies typically includes:

This cross-species reactivity is beneficial for comparative studies across model organisms. The conservation of reactivity suggests that the epitopes recognized by these antibodies are relatively conserved regions of the RRP4 protein across mammalian species .

What are the optimal storage conditions for maintaining RRP4 antibody activity?

For optimal preservation of RRP4 antibody activity, the following storage conditions are recommended:

• Short-term storage: Store at 4°C (refrigerated)

• Long-term storage: Aliquot and store at -20°C

• Avoid freeze-thaw cycles: Repeated freezing and thawing significantly reduces antibody activity

Most commercial RRP4 antibodies are supplied in buffers containing stabilizers such as:

• PBS (pH 7.2) with 40% glycerol

• 50mM Tris-Glycine (pH 7.4) with 0.15M NaCl, 40% glycerol, and 0.05% BSA

• Low concentrations of sodium azide (0.01-0.05%) as a preservative

These stabilizing components help maintain antibody activity during storage periods. When working with the antibody, it's advisable to remove only the amount needed for immediate use while keeping the stock solution properly stored to maximize shelf life.

How can RRP4 antibodies be utilized to study RNA exosome complex composition and heterogeneity?

RRP4 antibodies have been instrumental in revealing the heterogeneous nature of RNA exosome complexes in vivo. Research has demonstrated that:

• Co-immunoprecipitation with RRP4 antibodies: Using Rrp4-specific antibodies, researchers have successfully co-immunoprecipitated Csl4 (another exosome cap protein) and vice versa, providing direct evidence for the presence of heteromeric RNA-binding caps in the exosome complex in vivo . This methodology revealed that:

  • The soluble exosome contains different proportions of DnaG and Csl4 compared to the insoluble exosome fraction

  • The insoluble exosome co-sediments with ribosomal subunits in sucrose density gradients

• Differential centrifugation followed by immunoprecipitation: This approach separates soluble and insoluble exosome fractions, allowing analysis of compartment-specific exosome compositions using RRP4 antibodies .

• Density gradient analysis: When combined with antibody detection, this technique provides insights into the association of RRP4-containing exosome complexes with other cellular components, such as ribosomal subunits .

For researchers interested in exosome complex heterogeneity, a workflow involving cell fractionation followed by immunoprecipitation with RRP4 antibodies and subsequent mass spectrometry analysis can reveal compartment-specific interaction partners and complex compositions.

What is known about RRP4's poly(A) specificity mechanism and how can antibodies help investigate this property?

RRP4 confers strong poly(A) specificity to the exosome complex, but the precise molecular mechanism remains an area of active investigation. Research has demonstrated that:

RRP4 antibodies can facilitate these studies through:

• Immunodepletion of endogenous RRP4 to create a background for structure-function studies

• Verification of complex formation with mutant RRP4 proteins

• Immunoprecipitation of differentially reconstituted complexes for activity assays

• Detection of RRP4 association with specific RNA substrates through RNA-protein immunoprecipitation

These approaches can help determine the structural basis for RRP4's poly(A) specificity, which remains an important question in RNA processing research.

What are the cellular localization patterns of RRP4 and how can immunofluorescence techniques be optimized?

RRP4 exhibits both nuclear and cytoplasmic localization, consistent with the RNA exosome complex's functions in both compartments . For optimal immunofluorescence detection of RRP4:

• Fixation methods:

  • 4% paraformaldehyde (10-15 minutes at room temperature) preserves cell morphology

  • Methanol fixation (-20°C for 10 minutes) may provide better antigen accessibility

  • Comparison of both methods is recommended for new experimental systems

• Permeabilization optimization:

  • 0.1-0.5% Triton X-100 (10 minutes) for nuclear penetration

  • 0.05-0.1% Saponin for milder permeabilization that better preserves cytoplasmic structures

• Blocking and antibody incubation:

  • 5% normal serum (from the species of secondary antibody origin)

  • 1% BSA in PBS with 0.1% Tween-20

  • Overnight primary antibody incubation at 4°C at 1:50-1:200 dilution

  • 1-2 hour room temperature incubation for secondary antibodies

• Co-localization markers:

  • Nucleolar markers (fibrillarin or nucleolin) to assess association with rRNA processing sites

  • P-body markers (DCP1 or GW182) to evaluate cytoplasmic RNA degradation sites

  • Nuclear speckle markers (SC35) to examine association with splicing/RNA processing centers

The distinct nuclear-cytoplasmic distribution pattern can provide insights into RRP4's functional compartmentalization and possible translocation under different cellular conditions or stresses.

What are the common technical challenges with RRP4 Western blots and how can they be addressed?

Researchers working with RRP4 antibodies in Western blot applications may encounter several technical challenges:

For optimal detection of RRP4 (~33 kDa) in Western blots:

• Use 10-12% polyacrylamide gels for better resolution in the 30-40 kDa range

• Consider wet transfer methods for more efficient protein transfer

• When validating new antibody batches, perform parallel testing with previously validated lots

• For low abundance samples, consider immunoprecipitation followed by Western blot

How can researchers verify RRP4 antibody specificity in their experimental systems?

Verifying antibody specificity is crucial for reliable RRP4 research. Several complementary approaches are recommended:

• Genetic knockdown/knockout controls:

  • siRNA/shRNA knockdown of RRP4/EXOSC2

  • CRISPR/Cas9-mediated knockout (if not lethal)

  • Analysis of signal reduction/elimination in Western blot or immunostaining

• Peptide competition assays:

  • Pre-incubate antibody with immunizing peptide (if available)

  • Observe elimination of specific signal

  • Include non-specific peptide as negative control

• Orthogonal detection methods:

  • Compare results with alternative antibodies targeting different RRP4 epitopes

  • Use tagged RRP4 constructs (GFP, FLAG, etc.) with tag-specific antibodies

  • Validate with mass spectrometry of immunoprecipitated material

• Cross-species validation:

  • Test antibody in species with known RRP4 sequence homology

  • Observe consistent banding patterns adjusted for species-specific molecular weight variations

• Functional validation:

  • Immunodepletion of RRP4 followed by functional assays

  • Reconstitution experiments with purified components

A systematic validation approach combining multiple methods provides the strongest evidence for antibody specificity and increases confidence in experimental results.

What considerations are important when using RRP4 antibodies for immunoprecipitation of RNA exosome complexes?

Immunoprecipitation (IP) of RRP4 to study exosome complexes requires careful optimization:

• Buffer composition optimization:

  • Salt concentration: 100-150 mM NaCl maintains complex integrity while reducing non-specific interactions

  • Detergent selection: Mild non-ionic detergents (0.1-0.5% NP-40 or 0.1% Triton X-100) preserve protein-protein interactions

  • Divalent cations: Include 1-5 mM MgCl₂ to stabilize RNA-dependent interactions

  • RNase inhibitors: Add if RNA-protein interactions need to be preserved

• Cross-linking considerations:

  • Reversible protein-protein cross-linkers (DSP or formaldehyde) can stabilize transient interactions

  • UV cross-linking for RNA-protein interactions if studying RRP4-RNA associations

  • Optimize cross-linking time to balance complex capture with epitope accessibility

• Antibody selection and coupling:

  • Verify the antibody's IP efficiency in pilot experiments

  • Consider pre-clearing lysates with non-immune IgG

  • Direct antibody conjugation to beads may improve specificity and reduce background

  • For pull-down of intact complexes, epitope accessibility within the complex must be considered

• Validation experiments:

  • Western blot for known exosome components (Rrp41, Rrp42, Csl4) in IP material

  • Compare composition between different cellular fractions (soluble vs. insoluble)

  • Assess RNA content and degradation activity of immunoprecipitated complexes

Research has successfully used RRP4 antibodies to demonstrate the presence of heteromeric RNA-binding caps in vivo and to identify novel interaction partners like EF1-alpha in soluble exosome fractions . These approaches can be adapted for studying different aspects of exosome biology.

How can RRP4 antibodies contribute to understanding RNA exosome dysfunction in disease states?

RNA exosome dysfunction has been implicated in various diseases, and RRP4 antibodies can provide valuable insights through several research approaches:

• Expression and localization analysis:

  • Comparative immunohistochemistry of normal vs. disease tissues

  • Subcellular fractionation followed by Western blot to detect compartment-specific alterations

  • Quantitative analysis of RRP4 levels in patient-derived samples

• Complex composition analysis:

  • Immunoprecipitation with RRP4 antibodies followed by mass spectrometry

  • Comparative analysis of exosome complex components between normal and diseased states

  • Detection of disease-specific interaction partners or complex alterations

• Functional assays:

  • RNA degradation activity measurements in immunopurified complexes

  • Substrate specificity changes in disease-associated exosomes

  • RRP4 association with specific RNA targets in disease conditions

• Mutation-specific approaches:

  • Generation of antibodies recognizing disease-associated RRP4 variants

  • Analysis of mutant protein stability, localization, and complex formation

These methodologies can help elucidate the role of RNA exosome dysfunction in conditions where RNA processing and degradation pathways are dysregulated, including certain neurodegenerative disorders and cancers where aberrant RNA metabolism has been implicated.

What methodological approaches can be used to study post-translational modifications of RRP4?

Post-translational modifications (PTMs) can significantly impact RRP4 function, localization, and complex formation. Several approaches can be employed to study RRP4 PTMs:

• PTM-specific detection methods:

  • Phosphorylation: Phos-tag gels followed by Western blot with RRP4 antibodies

  • Ubiquitination: Immunoprecipitation under denaturing conditions followed by ubiquitin detection

  • SUMOylation: SUMO-trap approaches combined with RRP4 antibody detection

  • General PTM screening: Mass spectrometry of immunopurified RRP4

• Modification site mapping workflow:

  • Immunoprecipitation of RRP4 from cells under various conditions

  • In-gel or in-solution digestion of purified protein

  • LC-MS/MS analysis with PTM-focused search parameters

  • Validation with site-specific antibodies or mutagenesis

• Functional impact assessment:

  • Correlation of PTM status with RNA processing activity

  • Analysis of PTM-dependent protein interactions

  • Cell cycle, stress response, or differentiation-associated PTM changes

• PTM enzyme identification:

  • Candidate approach testing known kinases, ubiquitin ligases, etc.

  • Proximity labeling approaches to identify modification enzymes in the RRP4 vicinity

  • Small molecule inhibitor screening to identify regulatory pathways

Studying RRP4 PTMs can provide insights into regulatory mechanisms controlling exosome function in different cellular contexts and may reveal novel therapeutic targets for conditions involving RNA processing dysregulation.

How might advanced microscopy techniques enhance our understanding of RRP4 dynamics when combined with appropriate antibodies?

Advanced microscopy approaches, when combined with RRP4 antibodies, offer powerful tools for studying dynamic aspects of exosome biology:

• Super-resolution microscopy applications:

  • STORM/PALM imaging with directly labeled RRP4 antibodies to visualize nanoscale distribution

  • SIM microscopy for improved resolution of RRP4 localization relative to nuclear structures

  • Expansion microscopy to physically enlarge specimens for enhanced visualization of RRP4-containing complexes

• Live-cell imaging approaches:

  • CRISPR knock-in of fluorescent tags at the endogenous RRP4 locus

  • Validation of tagged constructs with RRP4 antibodies

  • Combined with FRAP (Fluorescence Recovery After Photobleaching) to assess mobility and turnover rates

  • Single-particle tracking to monitor individual complex movements

• Proximity labeling technologies:

  • APEX2 or BioID fusions to RRP4 for mapping the local protein environment

  • Validation of proximity labeling results with conventional co-immunoprecipitation using RRP4 antibodies

  • Spatial proteomics to determine compartment-specific interaction networks

• Correlative light and electron microscopy (CLEM):

  • Primary detection with fluorescent-labeled RRP4 antibodies

  • Secondary detection with gold-conjugated secondary antibodies

  • Ultrastructural context of RRP4-containing complexes

These advanced imaging approaches can reveal new insights into the dynamic behavior of RRP4-containing exosome complexes, their trafficking between cellular compartments, and their association with specific subcellular structures under various physiological and pathological conditions.

What considerations are important when developing research strategies to study RRP4's role in specific RNA processing pathways?

When investigating RRP4's role in specific RNA processing pathways, several methodological considerations are essential:

• Substrate-specific experimental design:

  • RNA immunoprecipitation (RIP) with RRP4 antibodies to identify bound RNA species

  • CLIP-seq approaches to map binding sites with nucleotide resolution

  • In vitro reconstitution with purified components to assess direct effects

  • Degradation assays with different RNA substrates to determine pathway specificity

• Cellular context considerations:

  • Cell type-specific expression patterns of RRP4 and associated factors

  • Analysis of nuclear vs. cytoplasmic functions with appropriate fractionation controls

  • Stress, cell cycle, or differentiation-dependent regulation

  • Integration with other RNA processing pathways

• Genetic manipulation strategies:

  • Conditional/inducible knockdown to bypass essential function lethality

  • Domain-specific mutations to separate different functional aspects

  • Complementation assays with wild-type vs. mutant RRP4 constructs

  • Validation of protein expression using RRP4 antibodies

• Comprehensive readouts:

  • RNA-seq to assess global effects on RNA processing and stability

  • Targeted analysis of specific substrates (e.g., histone mRNAs, AREs-containing transcripts)

  • Metabolic labeling approaches to measure RNA synthesis and decay rates

  • Integration of transcriptomic and proteomic data

Research has shown that RRP4 exhibits distinct properties such as strong poly(A) specificity , suggesting specialized roles in certain RNA processing pathways. A comprehensive experimental approach combining biochemical, genetic, and genomic methods is ideal for elucidating these pathway-specific functions.

What emerging technologies might enhance RRP4 antibody utility in future research?

Several emerging technologies show promise for expanding the applications of RRP4 antibodies in advanced research contexts:

• Single-cell approaches:

  • Adaptation of RRP4 antibodies for single-cell Western blot technologies

  • Integration with single-cell RNA-seq to correlate protein expression with transcriptome

  • Mass cytometry (CyTOF) with metal-conjugated RRP4 antibodies for high-dimensional analysis

• Spatial biology applications:

  • Spatial transcriptomics combined with RRP4 immunodetection

  • Multiplexed ion beam imaging (MIBI) with metal-labeled antibodies

  • Highly multiplexed immunofluorescence (CODEX, Vectra) to map RRP4 within tissue architecture

• Protein engineering advancements:

  • Development of high-affinity recombinant antibody fragments (nanobodies, scFvs)

  • Split-antibody complementation systems for detecting protein interactions

  • Antibody-based proximity labeling for identifying transient interactors

• Diagnostic applications:

  • Development of sensitive detection systems for alterations in RRP4 expression or localization

  • Integration with liquid biopsy approaches for exosome complex component analysis

  • Correlation of RRP4 status with disease progression or treatment response